Google DeepMind
The company will use the funds for AI research and to advance its programs in clinical development.
AlphaProteo was created to advance drug design and disease understanding by helping researchers configure high-strength proteins that bind to molecules.
Tx-LLM was fine-tuned from Google's Med-PaLM 2 and created to analyze a variety of chemical or biological entities to assist with the drug-discovery pipeline.
Med-Gemini-3D can read 3D scans, generate radiology reports and answer questions, while Med-Gemini-Polygenic can predict health outcomes based on genomic data.
The tech giant revealed it created an LLM optimized for diagnostic reasoning with the ability to generate a differential diagnosis or assist clinicians in coming to a diagnosis.
The app was used by the U.K.’s National Health Service to help clinicians access patient information, but most NHS Trusts had reportedly stopped using it.
The Alphabet subsidiary aced a long-running research competition with its deep-learning system, called AlphaFold.